Abivax is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory diseases, viral infections, and cancer using its proprietary immune-enhancing technology platforms.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!